Clavulanic acid
| RX-10100 | |
|---|---|
| Molecular structure via molpic based on CDK |
| Rotamer [] | |
|---|---|
| Conformer structure via 3Dmol.js |
| Physical properties [] | |
|---|---|
| Molecular mass | 199.16 g/mol [1] |
| Melting point | 117.5-118 [1] |
| Solubility | 3.37e+02 g/L [1] |
| Predicted LogP | -1.2 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C8H9NO5 [1] |
| IUPAC name | (2R,3Z,5R)-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylic acid [1] |
| SMILES | C1[C@@H]2N(C1=O)[C@H](/C(=C/CO)/O2)C(=O)O [1] |
| InChI | InChI=1S/C8H9NO5/c10-2-1-4-7(8(12)13)9-5(11)3-6(9)14-4/h1,6-7,10H,2-3H2,(H,12,13)/b4-1-/t6-,7-/m1/s1 [1] |
| InChIKey | HZZVJAQRINQKSD-PBFISZAISA-N [1] |
| Pharmacokinetics[] | |
|---|---|
| Elimination half-life | 0.8 – 1.2 hours |
(Redirected from Clavulanic acid)
Clavulanic acid (also known as Clavulanic Acid, Acido clavulanico, Acide clavulanique, Antibiotic MM 14151, acidum clavulanicum, Clavulansaeure, MM 14151, BRL-14151, Serdaxin or BRL 14151) is a antibiotic substance of the amine class.
Chemistry
Stereochemistry []
Clavulanic acid is a absolute mixture.
Legal status []
- Australia: Clavulanic acid is a Schedule 4 substance.
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 5280980, Clavulanic acid. Accessed October 16, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/5280980
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Clavulanic acid. UNII: 23521W1S24. Global Substance Registration System. Accessed October 16, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/23521W1S24